SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Net Sales | ₹263 Cr | ₹224 Cr | ₹220 Cr | ₹18,482,242 Cr | ₹184 Cr |
What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹263 Cr |
| Mar2024 | ₹224 Cr |
| Mar2023 | ₹220 Cr |
| Mar2022 | ₹18,482,242 Cr |
| Mar2017 | ₹184 Cr |
How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹263 Cr | 17.45 | |
| Mar2024 | ₹224 Cr | 2.09 | |
| Mar2023 | ₹220 Cr | -100.00 | |
| Mar2022 | ₹18,482,242 Cr | 10,050,222.98 | |
| Mar2017 | ₹184 Cr | - | |
Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,102.6 Cr | -2.9% | -14.4% | -23.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -2.9% |
-14.4% |
-23.5% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses